336 related articles for article (PubMed ID: 27333444)
1. Atf6α deficiency suppresses microglial activation and ameliorates pathology of experimental autoimmune encephalomyelitis.
Ta HM; Le TM; Ishii H; Takarada-Iemata M; Hattori T; Hashida K; Yamamoto Y; Mori K; Takahashi R; Kitao Y; Hori O
J Neurochem; 2016 Dec; 139(6):1124-1137. PubMed ID: 27333444
[TBL] [Abstract][Full Text] [Related]
2. Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases.
Stone S; Wu S; Jamison S; Durose W; Pallais JP; Lin W
Glia; 2018 Jul; 66(7):1331-1345. PubMed ID: 29436030
[TBL] [Abstract][Full Text] [Related]
3. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
4. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
5. Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.
Li G; Yamasaki R; Fang M; Masaki K; Ochi H; Matsushita T; Kira JI
Sci Rep; 2018 Jan; 8(1):1933. PubMed ID: 29386552
[TBL] [Abstract][Full Text] [Related]
6. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI
Front Immunol; 2018; 9():2588. PubMed ID: 30464764
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
[TBL] [Abstract][Full Text] [Related]
8. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
9. Absence of system x
Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
[TBL] [Abstract][Full Text] [Related]
10. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
11. The nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis.
Gharagozloo M; Mahvelati TM; Imbeault E; Gris P; Zerif E; Bobbala D; Ilangumaran S; Amrani A; Gris D
J Neuroinflammation; 2015 Oct; 12():198. PubMed ID: 26521018
[TBL] [Abstract][Full Text] [Related]
12. Ndrg2 deficiency ameliorates neurodegeneration in experimental autoimmune encephalomyelitis.
Le TM; Takarada-Iemata M; Ta HM; Roboon J; Ishii H; Tamatani T; Kitao Y; Hattori T; Hori O
J Neurochem; 2018 Apr; 145(2):139-153. PubMed ID: 29315585
[TBL] [Abstract][Full Text] [Related]
13. Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis.
Kuo PC; Weng WT; Scofield BA; Paraiso HC; Brown DA; Wang PY; Yu IC; Yen JH
J Neuroinflammation; 2020 Apr; 17(1):138. PubMed ID: 32349768
[TBL] [Abstract][Full Text] [Related]
14. LIGHT (TNFSF14/CD258) is a decisive factor for recovery from experimental autoimmune encephalomyelitis.
Maña P; Liñares D; Silva DG; Fordham S; Scheu S; Pfeffer K; Staykova M; Bertram EM
J Immunol; 2013 Jul; 191(1):154-63. PubMed ID: 23720813
[TBL] [Abstract][Full Text] [Related]
15. Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response.
Cassiani-Ingoni R; Muraro PA; Magnus T; Reichert-Scrivner S; Schmidt J; Huh J; Quandt JA; Bratincsak A; Shahar T; Eusebi F; Sherman LS; Mattson MP; Martin R; Rao MS
J Neuropathol Exp Neurol; 2007 Jul; 66(7):637-49. PubMed ID: 17620989
[TBL] [Abstract][Full Text] [Related]
16. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
[TBL] [Abstract][Full Text] [Related]
17. p38 MAP Kinase Signaling in Microglia Plays a Sex-Specific Protective Role in CNS Autoimmunity and Regulates Microglial Transcriptional States.
McGill MM; Richman AR; Boyd JR; Sabikunnahar B; Lahue KG; Montgomery TL; Caldwell S; Varnum S; Frietze S; Krementsov DN
Front Immunol; 2021; 12():715311. PubMed ID: 34707603
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of colony-stimulating factor-1 in mouse spinal cord with experimental autoimmune encephalomyelitis correlates with microglial activation and neuronal loss.
Gushchina S; Pryce G; Yip PK; Wu D; Pallier P; Giovannoni G; Baker D; Bo X
Glia; 2018 Oct; 66(10):2108-2125. PubMed ID: 30144320
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.
Maresz K; Carrier EJ; Ponomarev ED; Hillard CJ; Dittel BN
J Neurochem; 2005 Oct; 95(2):437-45. PubMed ID: 16086683
[TBL] [Abstract][Full Text] [Related]
20. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
